IL34 and hepatocellular carcinoma: In mammary cancer and other tumors (i.e., teratoma, hepatocellular carcinoma), the pro-tumoral effect of IL-34 has been linked to the ability of the cytokine to promote the function of type 2 macrophages22–24.